SPYK04
Phase 1Active 2 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Locally Advanced or Metastatic Solid Tumors
Conditions
Locally Advanced or Metastatic Solid Tumors
Trial Timeline
Sep 10, 2020 → Sep 30, 2026
NCT ID
NCT04511845About SPYK04
SPYK04 is a phase 1 stage product being developed by Chugai Pharmaceutical for Locally Advanced or Metastatic Solid Tumors. The current trial status is active. This product is registered under clinical trial identifier NCT04511845. Target conditions include Locally Advanced or Metastatic Solid Tumors.
What happened to similar drugs?
5 of 20 similar drugs in Locally Advanced or Metastatic Solid Tumors were approved
Approved (5) Terminated (1) Active (14)
Hype Score Breakdown
Clinical
6
Activity
12
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04511845 | Phase 1 | Active |
Competing Products
20 competing products in Locally Advanced or Metastatic Solid Tumors